NCT07499908 (Citysky) is a Phase 1 clinical trial of CIT-013 high dose in Healthy Adult, sponsored by Citryll BV.

Who is sponsoring NCT07499908?

NCT07499908 is sponsored by Citryll BV.

What drugs are being tested in NCT07499908?

Interventions in NCT07499908: CIT-013 high dose, Placebo.

What condition does NCT07499908 study?

NCT07499908 studies Healthy Adult.

Is NCT07499908 still recruiting?

NCT07499908 is currently not yet recruiting. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07499908: Citysky

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phase 1 Trial to Evaluate 150 mg Subcutaneous CIT-013

Not yet recruiting Phase 1 Last updated 13 April 2026

What this trial tests

Phase 1 trial testing CIT-013 high dose in Healthy Adult in 10 participants. Not yet recruiting.

Timeline

31 May 2026

Primary endpoint
15 August 2026

31 October 2026

Quick facts

Lead sponsor	Citryll BV
Phase	Phase 1
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	10
Start date	31 May 2026
Primary completion	15 August 2026
Estimated completion	31 October 2026
Sites	1 location across Netherlands

Drugs / interventions tested

CIT-013 high dose — full drug profile →
Placebo

Conditions studied

Healthy Adult — all drugs for Healthy Adult →

Sponsor

Citryll BV — full company profile →

Who can join

Adults 18 to 75, any sex, with Healthy Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a phase 1, double-blind, randomized, placebo-controlled, single center, repeat-dose trial for the assessment of safety, tolerability, bioavailability and pharmacokinetic profiles of 150 mg CIT-013 in healthy adult volunteers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy Adult

Currently open trials in the same condition.

NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
NCT07343245 — A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs · Phase 1 · recruiting
NCT07414862 — The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training · NA · active not recruiting
NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting

Other Citryll BV trials

Trials by the same sponsor.

NCT07147959 — PET-Based Imaging of Radiolabeled CIT-013 · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07499908 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Citryll BV
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07499908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing